Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

I was concerned that the Primary endpoints were directed at 15 day results. Expecting a strong patient uptrend at this early time in humans may have been too aggressive. Damage to the Lungs may take longer than hoped to show healing effects.

The 'positive trending' is certainly better than colonquin/others which were a negative.

The Secondary endpoints seem more realistic with effects of treatment time allowing it to fully work. Seems by this data that at the 15 day period it will just begin affecting recovery and 'I hope' to see Ifenprodil show stronger results given the extra time periods in the 28 day Secondary data.
Time to being on ventilation or coming off along with overall mortality and final time spent in a Hospital were all set for 28 day analysis.
As stated in the PR, an EUA was granted for minor improvements from Rem. It was mentioned for a reason, I hope.
Ifenprodil doesn't seem to be the instant COVID-19 killer of our dreams but is showing some effectiveness and is safe with COVID patient's conditions. More time and that Data may still show Ifenprodil will be a stronger treatment than what is available now...JMHO...GLTA...

science guys???